Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series.

Cohen AK, Jaudon TW, Schurman EM, Kava L, Vogel JM, Haas-Godsil J, Lewis D, Crausman S, Leslie K, Bligh SC, Lizars G, Davids JD, Sran S, Peluso M, McCorkell L

Open source

DOI: 10.1038/s43856-024-00668-8
Published: 2025 Jan 6
Container: Communications medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s43856-024-00668-8,
  title = {Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series.},
  author = {Cohen AK and Jaudon TW and Schurman EM and Kava L and Vogel JM and Haas-Godsil J and Lewis D and Crausman S and Leslie K and Bligh SC and Lizars G and Davids JD and Sran S and Peluso M and McCorkell L},
  year = {2025},
  journal = {Communications medicine},
  doi = {10.1038/s43856-024-00668-8},
  url = {https://doi.org/10.1038/s43856-024-00668-8}
}

RIS

TY  - JOUR
TI  - Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series.
AU  - Cohen AK
AU  - Jaudon TW
AU  - Schurman EM
AU  - Kava L
AU  - Vogel JM
AU  - Haas-Godsil J
AU  - Lewis D
AU  - Crausman S
AU  - Leslie K
AU  - Bligh SC
AU  - Lizars G
AU  - Davids JD
AU  - Sran S
AU  - Peluso M
AU  - McCorkell L
PY  - 2025
JO  - Communications medicine
DO  - 10.1038/s43856-024-00668-8
UR  - https://doi.org/10.1038/s43856-024-00668-8
ER  -

APA

AK, C., TW, J., EM, S., L, K., JM, V., J, H., D, L., S, C., K, L., SC, B., G, L., JD, D., S, S., M, P., & L, M. (2025). Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series.. Communications medicine. https://doi.org/10.1038/s43856-024-00668-8

Source records

pubmed · retrieved 2026-09-26T23:52:43.699Z